These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15153320)

  • 1. Breast cancer detection rates, and standardised detection ratios for prevalence screening in the New Zealand breast cancer screening programme.
    Richardson A; Graham P; Brown T; Smale P; Cox B
    J Med Screen; 2004; 11(2):65-9. PubMed ID: 15153320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nationwide breast cancer screening fully accomplished; results from the implementation phase 1990-1997. National Evaluation Team for Breast Cancer Screening].
    Ned Tijdschr Geneeskd; 2000 Jun; 144(23):1124-9. PubMed ID: 10876708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes of the Otago-Southland Breast Cancer Screening Programme 1991-1996.
    Doyle TC; Elwood JM; Smale P; Berkeley BB; Blennerhassett JB; Miller AP; Chartres SM; Hunter MH; Packer SG; Pfeifer M
    N Z Med J; 1998 Oct; 111(1075):380-3. PubMed ID: 9830418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modelling the impact of detecting and treating ductal carcinoma in situ in a breast screening programme.
    McCann J; Treasure P; Duffy S
    J Med Screen; 2004; 11(3):117-25. PubMed ID: 15333269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing incidence of breast cancer: distinguishing between the effects of birth cohort and a national breast screening programme.
    Brown SB; Morrison DS; Cooke TG
    Breast Cancer Res Treat; 2009 Aug; 116(3):603-7. PubMed ID: 18855136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-specific interval breast cancers in New South Wales and meta-analysis of studies of women aged 40-49 years.
    Taylor R; Page A; Bampton D; Estoesta J; Rickard M
    J Med Screen; 2004; 11(4):199-206. PubMed ID: 15563775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interval cancer incidence and episode sensitivity in the Norrbotten Mammography Screening Programme, Sweden.
    Bordás P; Jonsson H; Nyström L; Lenner P
    J Med Screen; 2009; 16(1):39-45. PubMed ID: 19349530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The costs of mammography screening in New Zealand: evidence from the pilot programmes.
    Menon A; Devlin NJ; Richardson AK
    N Z Med J; 1994 Dec; 107(991):501-3. PubMed ID: 7830979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population-based breast cancer screening: policy advice for a New Zealand screening programme. Breast Cancer Screening Policy Advisory Group.
    N Z Med J; 1998 Apr; 111(1064):138-42. PubMed ID: 9612474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ascertainment and evaluation of interval cancers in population-based mammography screening programmes: a collaborative study in four European centres.
    Törnberg S; Codd M; Rodrigues V; Segnan N; Ponti A
    J Med Screen; 2005; 12(1):43-9. PubMed ID: 15814019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer incidence after the introduction of mammography screening: what should be expected?
    Svendsen AL; Olsen AH; von Euler-Chelpin M; Lynge E
    Cancer; 2006 May; 106(9):1883-90. PubMed ID: 16572411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer in New Zealand: trends, patterns, and data quality.
    Armstrong W; Borman B
    N Z Med J; 1996 Jun; 109(1024):221-4. PubMed ID: 8769030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Contributions of the epidemiological cancer registries to the evaluation of mammography screening in Germany].
    Urbschat I; Kieschke J; Schlanstedt-Jahn U; von Gehlen S; Thiel A; Jensch P
    Gesundheitswesen; 2005 Jul; 67(7):448-54. PubMed ID: 16103967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of breast cancer screening in countries with intermediate and increasing incidence of breast cancer.
    Wu GH; Chen LS; Chang KJ; Hou MF; Chen SC; Liu TJ; Huang CS; Hsu GC; Yu CC; Jeng LL; Chen ST; Chou YH; Wu CY; Shin-Lan K; Chen TH;
    J Med Screen; 2006; 13 Suppl 1():S23-7. PubMed ID: 17227638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer screening in Singapore, with particular reference to breast, cervical and colorectal cancer screening.
    Yeoh KG; Chew L; Wang SC
    J Med Screen; 2006; 13 Suppl 1():S14-9. PubMed ID: 17227636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Breast complaints during the Dutch nationwide breast cancer screening program: increased risk of referral and of breast cancer].
    van Bon-Martens MJ; Klingenberg H; Dijkstra HA; Peeters PH
    Ned Tijdschr Geneeskd; 2001 Jun; 145(22):1067-71. PubMed ID: 11414168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved survival rate for women with interval breast cancer - results from the breast cancer screening programme in Malmö, Sweden 1976-1999.
    Zackrisson S; Janzon L; Manjer J; Andersson I
    J Med Screen; 2007; 14(3):138-43. PubMed ID: 17925086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a community-based intervention to enhance breast cancer screening practices in Brazil.
    Thuler LC; Freitas HG
    J Eval Clin Pract; 2008 Dec; 14(6):1012-7. PubMed ID: 18759754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening caused rising incidence rates of ductal carcinoma in situ of the breast.
    van Steenbergen LN; Voogd AC; Roukema JA; Louwman WJ; Duijm LE; Coebergh JW; van de Poll-Franse LV
    Breast Cancer Res Treat; 2009 May; 115(1):181-3. PubMed ID: 18516674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The National Breast Screening Programme: the first 5,000 women screened in Northern Ireland.
    O'Doherty AJ; Crothers JG; Majury CW
    Ulster Med J; 1991 Oct; 60(2):150-3. PubMed ID: 1785147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.